ATE155039T1 - Mit zucker überzogene pharmazeutische dosierungseinheit - Google Patents
Mit zucker überzogene pharmazeutische dosierungseinheitInfo
- Publication number
- ATE155039T1 ATE155039T1 AT94203732T AT94203732T ATE155039T1 AT E155039 T1 ATE155039 T1 AT E155039T1 AT 94203732 T AT94203732 T AT 94203732T AT 94203732 T AT94203732 T AT 94203732T AT E155039 T1 ATE155039 T1 AT E155039T1
- Authority
- AT
- Austria
- Prior art keywords
- dosage unit
- pharmaceutical dosage
- sugar coated
- coated pharmaceutical
- sugar
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 abstract 3
- ATXHVCQZZJYMCF-XUDSTZEESA-N Allylestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)CC=C)[C@@H]4[C@@H]3CCC2=C1 ATXHVCQZZJYMCF-XUDSTZEESA-N 0.000 abstract 1
- YNVGQYHLRCDXFQ-XGXHKTLJSA-N Lynestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 YNVGQYHLRCDXFQ-XGXHKTLJSA-N 0.000 abstract 1
- 229960002692 allylestrenol Drugs 0.000 abstract 1
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 1
- 229960004976 desogestrel Drugs 0.000 abstract 1
- AOXRBFRFYPMWLR-XGXHKTLJSA-N ethylestrenol Chemical compound C1CC2=CCCC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](CC)(O)[C@@]1(C)CC2 AOXRBFRFYPMWLR-XGXHKTLJSA-N 0.000 abstract 1
- 229960001460 ethylestrenol Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229960001910 lynestrenol Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93203645 | 1993-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE155039T1 true ATE155039T1 (de) | 1997-07-15 |
Family
ID=8214236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94203732T ATE155039T1 (de) | 1993-12-23 | 1994-12-22 | Mit zucker überzogene pharmazeutische dosierungseinheit |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5662936A (de) |
| EP (1) | EP0659432B1 (de) |
| JP (1) | JPH07206681A (de) |
| KR (1) | KR100330560B1 (de) |
| CN (1) | CN1108929A (de) |
| AT (1) | ATE155039T1 (de) |
| AU (1) | AU685538B2 (de) |
| CA (1) | CA2138451C (de) |
| DE (2) | DE659432T1 (de) |
| DK (1) | DK0659432T3 (de) |
| ES (1) | ES2105501T3 (de) |
| FI (1) | FI116035B (de) |
| GR (1) | GR3024817T3 (de) |
| NO (1) | NO305273B1 (de) |
| NZ (1) | NZ270228A (de) |
| ZA (1) | ZA949929B (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
| ES2218556T3 (es) * | 1994-11-22 | 2004-11-16 | Balance Pharmaceuticals, Inc. | Metodos de contracepcion. |
| US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| DE69702985T2 (de) * | 1997-09-23 | 2001-02-15 | Akzo Nobel N.V., Arnheim/Arnhem | Steroid enthaltende Dosierungsformen mit einer steroiddichten Umhüllung |
| EP1183061B2 (de) | 1999-06-05 | 2012-10-17 | Innovata Biomed Limited | Verabreichungsystem für medikamente |
| GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
| EP1240261B1 (de) * | 1999-10-11 | 2004-02-18 | Innovata Biomed Limited | Medikamentenabgabevorrichtung mit einer feuchtigkeitsbeständigen beschichtung |
| US6254888B1 (en) | 2000-01-28 | 2001-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for coating pharmaceutical dosage forms |
| CA2403594A1 (en) * | 2000-03-27 | 2002-09-18 | Kyowa Hakko Kogyo Co., Ltd. | Granules having good taking property |
| JP5178982B2 (ja) * | 2000-05-18 | 2013-04-10 | セリックス， インコーポレイテッド | 経口投薬形態における、毒性コアの非毒性領域中へのカプセル化 |
| JP2002068965A (ja) * | 2000-08-31 | 2002-03-08 | Teikoku Hormone Mfg Co Ltd | 単層糖衣錠及びその製造方法 |
| WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
| US7303763B2 (en) * | 2001-02-12 | 2007-12-04 | Watson Laboratories, Inc. | Compositions for conjugated estrogens and associated methods |
| GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
| US8092831B2 (en) * | 2002-11-08 | 2012-01-10 | Andrx Pharmaceuticals, Llc | Antihistamine and decongestant system |
| WO2005102429A1 (en) | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| JP4705108B2 (ja) * | 2004-10-15 | 2011-06-22 | ズートツッカー アクチェンゲゼルシャフト マンハイム／オクセンフルト | 改良されたパンコーティング法 |
| JP4808453B2 (ja) * | 2005-08-26 | 2011-11-02 | 株式会社荏原製作所 | 研磨方法及び研磨装置 |
| JP2009509974A (ja) * | 2005-09-23 | 2009-03-12 | スレッシュオールド ファーマシューティカルズ， インコーポレイテッド | 抗癌治療 |
| RU2013135273A (ru) * | 2010-12-29 | 2015-02-10 | Нестек С.А. | Кондитерский продукт, содержащий агломерированный масляный порошок |
| RU2644189C2 (ru) * | 2012-07-03 | 2018-02-08 | Нестек С.А. | Кондитерский продукт, содержащий агломерированный масляный порошок |
| US20150290136A1 (en) * | 2012-11-22 | 2015-10-15 | Evonik Roehm Gmbh | Process for preparing a granulated product from a powder composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2736682A (en) * | 1954-10-11 | 1956-02-28 | Victor M Hermelin | Method of making a prolonged action medicinal tablet |
| US3576663A (en) * | 1967-05-29 | 1971-04-27 | Colorcon | Coated tablet |
| US3577512A (en) * | 1968-10-11 | 1971-05-04 | Nat Patent Dev Corp | Sustained release tablets |
| US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
| IE67345B1 (en) * | 1991-03-12 | 1996-03-20 | Akzo Nv | Low dose dry pharmaceutical preparations |
-
1994
- 1994-12-13 ZA ZA949929A patent/ZA949929B/xx unknown
- 1994-12-19 CA CA002138451A patent/CA2138451C/en not_active Expired - Fee Related
- 1994-12-20 JP JP6316645A patent/JPH07206681A/ja active Pending
- 1994-12-20 US US08/360,157 patent/US5662936A/en not_active Expired - Lifetime
- 1994-12-21 NZ NZ270228A patent/NZ270228A/en not_active IP Right Cessation
- 1994-12-22 AT AT94203732T patent/ATE155039T1/de not_active IP Right Cessation
- 1994-12-22 DE DE0659432T patent/DE659432T1/de active Pending
- 1994-12-22 EP EP94203732A patent/EP0659432B1/de not_active Expired - Lifetime
- 1994-12-22 DK DK94203732.6T patent/DK0659432T3/da active
- 1994-12-22 NO NO944991A patent/NO305273B1/no not_active IP Right Cessation
- 1994-12-22 ES ES94203732T patent/ES2105501T3/es not_active Expired - Lifetime
- 1994-12-22 KR KR1019940035926A patent/KR100330560B1/ko not_active Expired - Fee Related
- 1994-12-22 DE DE69404116T patent/DE69404116T2/de not_active Expired - Fee Related
- 1994-12-22 FI FI946043A patent/FI116035B/fi active IP Right Grant
- 1994-12-22 CN CN94119182A patent/CN1108929A/zh active Pending
- 1994-12-22 AU AU81684/94A patent/AU685538B2/en not_active Ceased
-
1997
- 1997-09-24 GR GR970402451T patent/GR3024817T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO944991L (no) | 1995-06-26 |
| NZ270228A (en) | 1995-09-26 |
| JPH07206681A (ja) | 1995-08-08 |
| AU685538B2 (en) | 1998-01-22 |
| DE69404116D1 (de) | 1997-08-14 |
| KR100330560B1 (ko) | 2002-09-05 |
| DE659432T1 (de) | 1997-01-30 |
| NO305273B1 (no) | 1999-05-03 |
| FI946043L (fi) | 1995-06-24 |
| GR3024817T3 (en) | 1998-01-30 |
| AU8168494A (en) | 1995-06-29 |
| CA2138451C (en) | 2007-04-24 |
| KR950016715A (ko) | 1995-07-20 |
| NO944991D0 (no) | 1994-12-22 |
| EP0659432B1 (de) | 1997-07-09 |
| US5662936A (en) | 1997-09-02 |
| CA2138451A1 (en) | 1995-06-24 |
| CN1108929A (zh) | 1995-09-27 |
| FI116035B (fi) | 2005-09-15 |
| ZA949929B (en) | 1995-08-23 |
| ES2105501T3 (es) | 1997-10-16 |
| EP0659432A1 (de) | 1995-06-28 |
| FI946043A0 (fi) | 1994-12-22 |
| DE69404116T2 (de) | 1997-11-13 |
| DK0659432T3 (da) | 1998-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE155039T1 (de) | Mit zucker überzogene pharmazeutische dosierungseinheit | |
| DK0402950T3 (da) | Behandling af postmenopausale ulemper | |
| EP0647133A4 (de) | Zusammensetzungen und verfahren zur verbesserte arzneimittelabgabe. | |
| IL103516A0 (en) | Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them | |
| MX9203417A (es) | Compuestos de diarilo antiateroescleroticos. | |
| GB9414966D0 (en) | Pharmaceutical compositions for the nasal administration of antiviral agents | |
| DE3686022D1 (de) | Monosaccharide enthaltende zusammensetzung zum heilen von wunden. | |
| FI930860A7 (fi) | Tropolonijohdoksia ja niiden farmaseuttisia koostumuksia iskeemisten s airauksien ehkäisemiseen ja hoitamiseen | |
| DE69004532D1 (de) | Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen. | |
| HUP9900924A3 (en) | Substituted 1 betha-d-arabinofuranosylcytosine derivatives and use of the same for producing pharmaceutical compositions having antitumor activity | |
| NO307447B1 (no) | Anvendelse av et pregnanderivat | |
| NZ332655A (en) | Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates | |
| NO934832D0 (no) | Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose | |
| HUP9901247A3 (en) | Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| ATE169922T1 (de) | Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase | |
| ITMI911445A0 (it) | Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva | |
| IT9021021A0 (it) | Composizioni farmaceutiche per la somministrazione orale di irudina | |
| AU8186291A (en) | A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs | |
| DK115789A (da) | Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi | |
| FR2685204B1 (fr) | Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine. | |
| HUP9801985A3 (en) | Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis | |
| FI950575A7 (fi) | 3- ja 5-substituoidut 1,2,3,4-oksatriatsoli-5-imiiniyhdisteet, niiden valmistusmenetelmä, mainittuja yhdisteitä sisältävä farmaseuttinen valmiste ja mainittujen yhdisteiden käyttö lääkkeiden valmistukseen | |
| ITMI911122A0 (it) | Composizioni per la terapia topica delle ustioni | |
| ES2184285T3 (es) | Compuestos farmaceuticos que contienen diclorhidrato de cinconina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |